Background: Patients with a pre-existing diagnosis of advanced cancer who discharge to a skilled nursing facility (SNF) after an acute care hospitalization rarely receive future oncologic treatment, have high readmission rates, and minimal hospice use. We aimed to evaluate survivorship of patients discharging to a SNF with a new diagnosis of cancer based on their […]

Case Presentation: Immunotherapy is an emerging therapeutic option in the field of oncology. Dermatological toxicities are the most prevalent immune-related adverse events associated with immunotherapy. Herein, we report a case of a 60-year-old male who developed localized bullous pemphigoid after nearly a year of treatment with a PD-1 inhibitor, nivolumab, for metastatic renal cell carcinoma. […]